Diagnos Laboratorium Utama PT Tbk (DGNS) - Total Liabilities

Latest as of June 2025: Rp110.07 Billion IDR ≈ $6.45 Million USD

Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has total liabilities worth Rp110.07 Billion IDR (≈ $6.45 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DGNS financial resilience to evaluate the company's liquid asset resilience ratio.

Diagnos Laboratorium Utama PT Tbk - Total Liabilities Trend (2017–2024)

This chart illustrates how Diagnos Laboratorium Utama PT Tbk's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Diagnos Laboratorium Utama PT Tbk.

Diagnos Laboratorium Utama PT Tbk Competitors by Total Liabilities

The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their total liabilities.

Company	Country	Total Liabilities
Tscan Therapeutics Inc NASDAQ:TCRX	USA	$102.43 Million
Agricore CS Holdings Berhad KLSE:0309	Malaysia	RM25.01 Million
Bio-View Ltd TA:BIOV	Israel	ILA8.26 Million
Central Motek Co Ltd KO:308170	Korea	₩265.69 Billion
North Eastern Carrying Corporation Limited NSE:NECCLTD	India	Rs1.45 Billion
Mirasol Resources Ltd V:MRZ	Canada	CA$3.44 Million
TMD Energy Limited NYSE MKT:TMDE	USA	$102.33 Million
Promimic AB ST:PRO	Sweden	Skr16.60 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Diagnos Laboratorium Utama PT Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DGNS equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diagnos Laboratorium Utama PT Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diagnos Laboratorium Utama PT Tbk (2017–2024)

The table below shows the annual total liabilities of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	Rp103.89 Billion ≈ $6.09 Million	+36.91%
2023-12-31	Rp75.88 Billion ≈ $4.45 Million	+157.17%
2022-12-31	Rp29.51 Billion ≈ $1.73 Million	-26.57%
2021-12-31	Rp40.18 Billion ≈ $2.35 Million	+19.92%
2020-12-31	Rp33.51 Billion ≈ $1.96 Million	+162.55%
2019-12-31	Rp12.76 Billion ≈ $747.85K	+14.23%
2018-12-31	Rp11.17 Billion ≈ $654.69K	+112.02%
2017-12-31	Rp5.27 Billion ≈ $308.79K	--

About Diagnos Laboratorium Utama PT Tbk

JK:DGNS Indonesia Diagnostics & Research

Market Cap

$20.36 Million

Rp347.50 Billion IDR

Market Cap Rank

#25143 Global

#547 in Indonesia

Share Price

Rp278.00

Change (1 day)

+3.73%

52-Week Range

Rp140.00 - Rp328.00

All Time High

Rp1408.74